Location History:
- Downingtown, PA (US) (2007)
- Downington, PA (US) (2010)
Company Filing History:
2 out of 1,309 
1 out of 18 Years Active: 2007-2010
Title: John Allen Robinson: Innovator in Bone and Lipid Cellular Signaling
Introduction
John Allen Robinson is a notable inventor based in Downingtown, PA (US). He has made significant contributions to the field of biomedical research, particularly in the areas of bone and lipid cellular signaling. With a total of 2 patents, Robinson's work has implications for the treatment and diagnosis of various disorders.
Latest Patents
Robinson's latest patents include "Reagents and method for modulating Dkk-mediated interactions" and "PTH responsive gene." The first patent provides reagents, compounds, compositions, and methods related to novel interactions of the extracellular domain of LRP5, HBM (a variant of LRP5), and/or LRP6 with Dkk, including Dkk-1. This invention is crucial for modulating lipid levels and bone mass, which can aid in the treatment of disorders such as osteoporosis. The second patent relates to a novel PTH gene and encompasses methods for screening, diagnosis, and the development of therapies for bone-related disorders.
Career Highlights
Throughout his career, Robinson has worked with prominent companies such as Wyeth and Oscient Pharmaceuticals Corporation. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Robinson has collaborated with talented individuals, including Kristina Allen and Anthony Anisowicz. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
John Allen Robinson is a distinguished inventor whose work in bone and lipid cellular signaling has the potential to transform the treatment of related disorders. His patents reflect a commitment to innovation and improving health outcomes.